Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Triebel

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Laboratory|August 25, 2015
High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal FunctionJakob Triebel, Aura Ileana Moreno-Vega, Miguel Vázquez-Membrillo, et al.
Angiogenesis|June 7, 2021
The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptideJuan Pablo Robles, Magdalena Zamora, Lourdes Siqueiros-Marquez, et al.
Journal of Neuroendocrinology|January 25, 2022
Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in ratsElva Adán-Castro, Lourdes Siqueiros-Márquez, Gabriela Ramírez-Hernández, et al.
The Journal of Clinical Investigation|August 3, 2013
Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritisNorma Adán, Jessica Guzmán-Morales, Maria G Ledesma-Colunga, et al.
Drug Development Research|October 7, 2025
Cardiovascular Safety of VIAN-c4551, an Antiangiogenic Peptide Derived From VasoinhibinMiguel A García-González, Alejandro D Miguel-Martínez, Abimael González-Hernández, et al.
Pediatric Research|November 15, 2016
Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurityLuz Consuelo Zepeda-Romero, Miguel Vazquez-Membrillo, Elva Adan-Castro, et al.
Translational Vision Science & Technology|September 4, 2020
Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic RetinopathyCarlos D Nuñez-Amaro, Aura Ileana Moreno-Vega, Elva Adan-Castro, et al.
Eye (London, England)|September 6, 2023
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trialCarlos D Núñez-Amaro, Mariana López, Elva Adán-Castro, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Laboratory|August 25, 2015
High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal FunctionJakob Triebel, Aura Ileana Moreno-Vega, Miguel Vázquez-Membrillo, et al.
Angiogenesis|June 7, 2021
The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptideJuan Pablo Robles, Magdalena Zamora, Lourdes Siqueiros-Marquez, et al.
Journal of Neuroendocrinology|January 25, 2022
Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in ratsElva Adán-Castro, Lourdes Siqueiros-Márquez, Gabriela Ramírez-Hernández, et al.
The Journal of Clinical Investigation|August 3, 2013
Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritisNorma Adán, Jessica Guzmán-Morales, Maria G Ledesma-Colunga, et al.
Drug Development Research|October 7, 2025
Cardiovascular Safety of VIAN-c4551, an Antiangiogenic Peptide Derived From VasoinhibinMiguel A García-González, Alejandro D Miguel-Martínez, Abimael González-Hernández, et al.
Pediatric Research|November 15, 2016
Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurityLuz Consuelo Zepeda-Romero, Miguel Vazquez-Membrillo, Elva Adan-Castro, et al.
Translational Vision Science & Technology|September 4, 2020
Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic RetinopathyCarlos D Nuñez-Amaro, Aura Ileana Moreno-Vega, Elva Adan-Castro, et al.
Eye (London, England)|September 6, 2023
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trialCarlos D Núñez-Amaro, Mariana López, Elva Adán-Castro, et al.
Pageof 6